The impact of the soluble epoxide hydrolase cascade on periodontal tissues

Periodontitis is a chronic inflammatory disease with complex pathogenesis. Uncontrolled inflammation is driven by the immune system in response to accumulation of oral biofilm that leads to alveolar bone loss, bleeding, increased periodontal probing depth with loss of attachment of the connective ti...

Full description

Bibliographic Details
Published in:	Frontiers in Dental Medicine
Main Authors:	Henrique Ballassini Abdalla, Thomas E. Van Dyke
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Subjects:	periodontitis inflammation lipid mediator soluble epoxide hydrolase (sEH) soluble epoxide hydrolase (sEH) inhibitors
Online Access:	https://www.frontiersin.org/articles/10.3389/fdmed.2023.1129371/full

Similar Items

Regulation of soluble epoxide hydrolase in renal-associated diseases: insights from potential mechanisms to clinical researches
by: Peng Gao, et al.
Published: (2024-02-01)

Coumarin and Moracin Derivatives from Mulberry Leaves (<i>Morus alba</i> L.) with Soluble Epoxide Hydrolase Inhibitory Activity
by: Hong Xu Li, et al.
Published: (2020-08-01)

The role of CYP-sEH derived lipid mediators in regulating mitochondrial biology and cellular senescence: implications for the aging heart
by: Ala Yousef, et al.
Published: (2024-12-01)

Essential Oils of <i>Laurus nobilis</i> L.: From Chemical Analysis to In Silico Investigation of Anti-Inflammatory Activity by Soluble Epoxide Hydrolase (sEH) Inhibition
by: Francesca Fantasma, et al.
Published: (2024-07-01)

Dissecting the Regulation of Arachidonic Acid Metabolites by Uncaria rhynchophylla (Miq). Miq. in Spontaneously Hypertensive Rats and the Predictive Target sEH in the Anti-Hypertensive Effect Based on Metabolomics and Molecular Docking
by: Lei Gao, et al.
Published: (2022-05-01)

Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors
by: Biswajit Kundu, et al.
Published: (2024-06-01)

Synthesis and structure–activity relationships for some novel diflapolin derivatives with benzimidazole subunit
by: Lisa Vieider, et al.
Published: (2022-12-01)

CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators
by: Zeqi Shi, et al.
Published: (2022-06-01)

Redox Regulation of Soluble Epoxide Hydrolase—Implications for Cardiovascular Health and Disease
by: Rebecca Charles, et al.
Published: (2022-06-01)

Inhibition of soluble epoxide hydrolase reverses bone loss in periodontitis by upregulating EMCN and inhibiting osteoclasts
by: Juanjuan Li, et al.
Published: (2024-11-01)

Evaluation and clinical implications of interactions between compound Danshen dropping pill and warfarin associated with the epoxide hydrolase gene
by: Xixi Chen, et al.
Published: (2023-05-01)

Association between the soluble epoxide hydrolase gene and preeclampsia
by: Ismail Sari, et al.
Published: (2017-10-01)

Inhibition of soluble epoxide hydrolase in endotoxin induced pig lung injury
by: Niklas Larsson, et al.
Published: (2025-09-01)

Role of soluble epoxide hydrolase in pain and depression comorbidity
by: Yuchen Bu, et al.
Published: (2024-04-01)

Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain
by: Fangyu Du, et al.
Published: (2022-03-01)

2-(Piperidin-4-yl)acetamides as Potent Inhibitors of Soluble Epoxide Hydrolase with Anti-Inflammatory Activity
by: Juan Martín-López, et al.
Published: (2021-12-01)

Screening, Identification and Mechanism of Action of Cod-Derived Soluble Epoxide Hydrolase Inhibitory Peptides Based on Pharmacophore Model
by: LIU Pan, TU Maolin, LIU Hanxiong, CHENG Shuzhen, XU Xianbing, DU Ming
Published: (2023-03-01)

Screening and Identification of Novel Soluble Epoxide Hydrolase Inhibitors from Corn Gluten Peptides
by: Jiamin Dang, et al.
Published: (2022-11-01)

Synthesis and Properties of 1,3-Disubstituted Ureas Containing (Adamantan-1-yl)(phenyl)methyl Fragment Based on One-Pot Direct Adamantane Moiety Inclusion
by: Vladimir D’yachenko, et al.
Published: (2023-04-01)

Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy
by: Mercè Pallàs, et al.
Published: (2020-05-01)

Soluble Epoxide Hydrolase Inhibitory Activity of Selaginellin Derivatives from Selaginella tamariscina
by: Jang Hoon Kim, et al.
Published: (2015-12-01)

Inhibitory activity of lignanamides isolated from hemp seed hulls(Cannabis sativa L.) against soluble epoxide hydrolase
by: Jang Hoon Kim, et al.
Published: (2023-09-01)

Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
by: Chun-Hu Wu, et al.
Published: (2017-11-01)

Inhibitory Activity of Quaternary Isoquinoline Alkaloids on Soluble Epoxide Hydrolase
by: Jang Hoon Kim, et al.
Published: (2022-09-01)

Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer’s Disease and Other Neurological Disorders: A Comprehensive Review
by: Manal Abdalla, et al.
Published: (2025-08-01)

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats
by: Matthieu Leuillier, et al.
Published: (2023-02-01)

Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development
by: Cindy B. McReynolds, et al.
Published: (2021-08-01)

Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model
by: Shuo Wang, et al.
Published: (2025-04-01)

In Vitro and In Silico Studies of Soluble Epoxide Hydrolase Inhibitors from the Roots of <i>Lycopus lucidus</i>
by: Yoo Kyong Han, et al.
Published: (2021-02-01)

Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity
by: Chia-Chi Hung, et al.
Published: (2019-06-01)

Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease
by: Aline Mello, et al.
Published: (2021-01-01)

Deletion of soluble epoxide hydrolase attenuates mice Hyperoxic acute lung injury
by: Li-Ping Liu, et al.
Published: (2018-04-01)

In Silico Modeling and Structural Analysis of Soluble Epoxide Hydrolase Inhibitors for Enhanced Therapeutic Design
by: Shuvam Sar, et al.
Published: (2023-08-01)

Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism
by: Michelle Flores Domingues, et al.
Published: (2020-01-01)

Inhibition of Soluble Epoxide Hydrolase for Renal Health
by: Jun-Yan Liu, et al.
Published: (2019-01-01)

Inhibition potential of phenolic constituents from the aerial parts of Tetrastigma hemsleyanum against soluble epoxide hydrolase and nitric oxide synthase
by: Cai Yi Wang, et al.
Published: (2019-01-01)

Soluble epoxide hydrolase deficiency attenuates airway inflammation in COPD via IRE1α/JNK/AP-1 signaling pathway
by: Yue Yu, et al.
Published: (2023-11-01)

Isolation of Two New Compounds and Other Constituents from Leaves of <i>Piper crocatum</i> and Study of Their Soluble Epoxide Hydrolase Activities
by: Hong Xu Li, et al.
Published: (2019-01-01)

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury
by: Matthieu Leuillier, et al.
Published: (2023-01-01)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
by: Cindy B. McReynolds, et al.
Published: (2019-05-01)